EXHIBIT 99
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ MITHRA SAWYER
________________________________________
(signature of holder)
Mithra Sawyer
________________________________________
Please Print Name(s)
60,000
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ E H&P INVESTMENTS
________________________________________
(signature of holder)
EH&P Investments
________________________________________
Please Print Name(s)
1,359,500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ TIBOR GAJDICS
________________________________________
(signature of holder)
Tibor Gajdics
________________________________________
Please Print Name(s)
1,359,500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ DECLAN CLANCY
________________________________________
(signature of holder)
Declan Clancy
________________________________________
Please Print Name(s)
1,359,000
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ RAY CAHILL
________________________________________
(signature of holder)
Ray Cahill
________________________________________
Please Print Name(s)
1,339,600
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ SHAMMA AZIZ
________________________________________
(signature of holder)
Shamma Aziz
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ WILLIAM LEGG
________________________________________
(signature of holder)
William Legg
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ HAVANA CONSULTANTS
________________________________________
(signature of holder)
Havana Consultants
________________________________________
Please Print Name(s)
6500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ James Adams
________________________________________
(signature of holder)
James Adams
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ FRANK ANDERSON
________________________________________
(signature of holder)
Frank Anderson
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ ERWIN HAAS
________________________________________
(signature of holder)
Erwin Haas
________________________________________
Please Print Name(s)
2000
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ ELEANOR CALDERWOOD
________________________________________
(signature of holder)
Eleanor Calderwood
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ DWIGHT CHAN
________________________________________
(signature of holder)
Dwight Chan
________________________________________
Please Print Name(s)
1000
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ KENNY CHAN
________________________________________
(signature of holder)
Kenny Chan
________________________________________
Please Print Name(s)
1000
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ WARWICK HOLLAND
________________________________________
(signature of holder)
Warwick Holland
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ BADRUDIN VISRAM
________________________________________
(signature of holder)
Badrudin Visram
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ SPENCER MICHIEL
________________________________________
(signature of holder)
Spencer Michiel
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ CHANTAL HILBERT
________________________________________
(signature of holder)
Chantal Hilbert
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ TERRI LOPUSHINSKY
________________________________________
(signature of holder)
Terry Lopushinsky
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ SONNY S. DOSANJH
________________________________________
(signature of holder)
Sonny S. Dosanih
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ KURT JOHNSON
________________________________________
(signature of holder)
Kurt Johnson
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ FRANK DEMPSEY
________________________________________
(signature of holder)
Frank Dempsey
________________________________________
Please Print Name(s)
5000
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ J. LARMOR
________________________________________
(signature of holder)
Jodi. Larmor
________________________________________
Please Print Name(s)
2000
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ DAVID FRANCO
________________________________________
(signature of holder)
David Franco
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ KENNETH GALLIE
________________________________________
(signature of holder)
Kenneth Gallie
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ TYLER ROTTARE
________________________________________
(signature of holder)
Tyler Rottare
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ BONNIE WHELAN
________________________________________
(signature of holder)
Bonnie Whelan
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ ANNA KURTYKA
________________________________________
(signature of holder)
Anna Kurtyka
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ ASIF VISRAM
________________________________________
(signature of holder)
Asif Visram
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ TRAVIS CHARUK
________________________________________
(signature of holder)
Travis Charuk
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ JILL HOLLIDAY H.G.
________________________________________
(signature of holder)
Jill Holliday H.G.
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ PAUL RASMUSSEN
________________________________________
(signature of holder)
Paul Rasmussen
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ GARY STEWART
________________________________________
(signature of holder)
Gary Stewart
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ HEATHER MCLAUGHLIN
________________________________________
(signature of holder)
Heather Mclaughlin
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ JAMES MOBERG
________________________________________
(signature of holder)
James Moberg
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ STEPHEN GAJDICS
________________________________________
(signature of holder)
Stephen Gajdics
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ CHRIS LARSON IN TRUST FOR JENNIFER LARSON
_____________________________________________
(signature of holder)
Chris Larson In Trust For Jennifer Larson
_____________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ CHRIS LARSON
________________________________________
(signature of holder)
Chris Larson
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ MICHAEL ABEY
________________________________________
(signature of holder)
Michael Abey
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ BARB CHARUK
________________________________________
(signature of holder)
Barb Charuk
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ A. ROSS GORRELL
________________________________________
(signature of holder)
A. Ross Gorrell
________________________________________
Please Print Name(s)
1000
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ MAXINE CLARK
________________________________________
(signature of holder)
Maxine Clark
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ SYLVIA GLINSBOCKEL
________________________________________
(signature of holder)
Sylvia Glinsbockel
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ ROBERT CHARUK
________________________________________
(signature of holder)
Robert Charuk
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ JAMES CHARUK
________________________________________
(signature of holder)
James Charuk
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ JILL HOLLIDAY
________________________________________
(signature of holder)
Jill Holliday
________________________________________
Please Print Name(s)
60,000
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ AL CHARUK
________________________________________
(signature of holder)
Al Charuk
________________________________________
Please Print Name(s)
1,359,500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ PATRICIA FLEMING
________________________________________
(signature of holder)
Patricia Fleming
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ RICHARD HAMILTON
________________________________________
(signature of holder)
Richard Hamilton
________________________________________
Please Print Name(s)
1500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ DONALD LYONS
________________________________________
(signature of holder)
Donald Lyons
________________________________________
Please Print Name(s)
1500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ JULIE FOLLETT
________________________________________
(signature of holder)
Julie Follett
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ ASIF VISRAM IN TRUST FOR SHAYANNE VISRAM
____________________________________________
(signature of holder)
Asif Visram in trust for Shayanne Visram
____________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned
January 31, 2005
Board of Directors
BV Pharmaceutical, Inc.
2890 Vassar Street, Suite A
Reno, Nevada 89509
Gentlemen:
The undersigned, a beneficial owner of the common stock of BV
Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common
Stock"), understands that the Company has filed with the U.S. Securities and
Exchange Commission a registration statement on Form SB-2, File No. 333-113726,
(the "Registration Statement"), for the registration of the Company's Common
Stock. As part of the disclosure included in the Registration Statement, the
Company has affirmatively stated that there will be no trading of the Company's
securities until such time as the Company is successfully registers or qualifies
the securities in the State of Texas or another state.
In order to insure that the aforesaid disclosure is adhered to, the
undersigned agrees, for the benefit of the Company, that he/she/it will not
offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, any shares of Common Stock of the
Company owned by him/her/it, or subsequently acquired through the exercise of
any options, warrants or rights, or conversion of any other security, or by
reason of any stock split or other distribution of stock, or grant options,
rights or warrants with respect to any such shares of Common Stock, until the
Company successfully registers or qualifies the Securities in the State of Texas
or another state. Furthermore, the undersigned will permit all certificates
evidencing his/her/its shares to be delivered to the Law Office of Michael J.
Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held
in trust until the securities are register or qualified in the State of Texas or
another state, at which time such certificates shall be returned to the
undersigned.
Very truly yours,
/s/ ANTHONY WONG
________________________________________
(signature of holder)
Anthony Wong
________________________________________
Please Print Name(s)
500
__________________________
Number of shares of Common
Stock owned